Novartis AG
Antibodies against growth differentiation factor 15 and uses thereof

Abstract:

Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as "GDF15"), and pharmaceutical compositions and methods of treatment comprising the same.